Clinical Trial Update: Pulse Reduction On Beta-blocker and Ivabradine Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating pulse reduction on beta-blocker and ivabradine therapy in patients with dilated cardiomyopathy and systolic heart fai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Beta-blocker
• IVABRADINE

Snippet

Sponsor: University of Colorado, Denver | Conditions: Dilated Cardiomyopathies, Idiopathic, Heart Failure, Systolic | Phase 4 | Status: COMPLETED